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Background
Alzheimer's Disease (AD) is the leading cause of demen-
tia, accounting for 70% of all dementias in old age. In
clinical practice the diagnosis is based on typical features
of the disease and exclusion of other conditions causing
dementia or cognitive dysfunction. So far the diagnosis of
definite AD can be confirmed only by brain biopsy or at
autopsy. Therefore, a reliable non- invasive diagnostic
method is mainly needed at this stage. In recent years, sci-
entists based on the cholinergic hypothesis of the Alzhe-
imer's disease1 developed systems of recording and
measuring the pupil size (pupillometry) finding out that
the pupil light reflex (PLR) responded in a particular way
in Alzheimer's disease patients. Today imaging methods
are an integral part of the diagnostic work-up of patients
with suspected dementia. MRI provides data of in vivo tis-
sue and enables evaluation of brain structures such as the
hippocampus.
To evaluate the pupillometry as an easy, non invasive and
efficient tool in AD diagnosis as well as the hippocampal
involvement in probable AD.
Materials and methods
Twenty three (23) healthy control subjects (10 males and
13 females) aged 71.87 ± 8.51 years and 23 probable
Alzheimer's disease patients, according to NINCDS-
ADRDA criteria, that matched age and sex entered the
study. The PLR was recorded with a fast video digital cam-
era (262 frames/sec). All subjects were free of any neuro-
logical or ophthalmological diseases, underwent standard
blood tests, and were free of any medication for at least 2
weeks prior to the testing. Patients with pathological Vis-
ual Evoked Potentials, Electroretinogram and MRI with
brain tumors or multifocal angiopathy were excluded. Tc-
99m-HMPAO SPECT study of the regional cerebral blood
flow (rCBF) was compatible with Alzheimer's disease. All
patients had a follow-up of minimum 2 years. The (PLR)
parameters that were studied are initial pupil radius (R1),
reaction time, minimum pupil radius (R2), amplitude
(Amp), maximum constriction velocity (VC max), maxi-
mum constriction acceleration (AC max). Hippocampal
pathology was evaluated by volumetric measurements
using thin, contiguous, optimally oriented image slices.
Results
A statistical significant reduction of initial pupil radius
(R1), Amplitude (Amp), maximum constriction velocity
(VC max) and maximum constriction acceleration (AC
max) was observed in the probable AD patient group
when compared to the control group. Difference concern-
ing the minimum pupil radius (R2) was not statistically
significant. Although the volume of the hippocampus,
evaluated by MRI, was not significantly affected by nor-
mal aging, it correlated significantly with clinical severity
assessed by MMSE, and with tests assessing delayed recall.
Discussion
The results from the pupillometry study suggest that a
cholinergic deficit, may be the main reason of the param-
eter differentiation between the two groups2. Given that
both AC max and VC max are significantly reduced in the
AD patients confirms the cholinergic deficit of AD since
Ach is considered the main neurotransmitter for the
movement we study (pupil light reflex). Although the vol-
ume of the hippocampus is not significantly affected by
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normal aging, bilateral volumetric hippocampal atrophy
in early AD. Concerning the findings, their reliability is
certain because of the number of subjects used, their strict
selection and the confirmation of AD diagnosis through-
out the follow-up period which had a mean time of 2
years.
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